Weight regain is common after discontinuing tirzepatide, as clinical studies have demonstrated significant weight increase in patients who stopped treatment
Patients on higher doses (1.0 mg or above) sometimes develop stronger appetite suppression that makes eating a challenge
doi: Interview with Dena Barsoum, MD, physical medicine and rehabilitation specialist with the Hospital for Special Surgery in New York City Interview with Joseph E
Nausea, vomiting, and delayed gastric emptying can affect adherence and quality of life
Authors relationships and activities The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work
Patients who rely heavily on online reviews for decision-making will find limited independent feedback